Trading Tips Blog

Nurix Therapeutics (NASDAQ: NRIX) is drawing serious Wall Street attention after Swiss pharma giant Roche signed an exclusive licensing and partnership deal worth up to $2.3 billion for Nurix's blood cancer drug bexobrutideg, known as bexdeg. The deal structure includes a $700 million upfront cash payment to Nurix — a massive balance sheet boost for a clinical-stage biotech — with the remaining $1.6 billion tied to development, regulatory, and commercial sales milestones. Roche's Deputy Chief Medical Officer Stefan Frings called ...
Read More About This

Yum Brands (NYSE: YUM) announced Tuesday it is selling Pizza Hut to private equity firm LongRange Capital and Yum China for $2.7 billion, ending the pizza chain's troubled relationship with its parent company after years of underperformance. The deal caps off what has been a prolonged strategic struggle for Pizza Hut, which has steadily lost market share to rivals Domino's and Papa John's while grappling with rising delivery costs and changing consumer habits. For Yum Brands investors, the sale is ...
Read More About This

SpaceX made a stunning debut on public markets, with shares rocketing more than 20% on Monday alone — one of the most explosive first-day moves for a major tech company in years. On Tuesday, the stock added another 3% in premarket trading, as investors continued to pile in on the back of CEO Elon Musk's ambitious growth projections. Musk said Sunday that SpaceX "might be able to reach approximately $1 trillion in revenue" by 2030, a statement that sent retail ...
Read More About This

Look, finding a good stock is like finding a decent coffee shop in a new city—you've got to know what you're looking for, and you can't just follow the hype. That's where value investing comes in, and honestly, it's the approach that's made legends like Warren Buffett ridiculously wealthy. Value stocks are basically companies trading for less than they're actually worth. Think of it as buying a designer jacket at a thrift store—same quality, fraction of the price. The market's just ...
Read More About This

Here's the thing about the AI boom: everyone's obsessed with the flashy stuff—the big language models, the ChatGPT drama, the "AI will replace your job" headlines. But according to Dan Ives, one of Wall Street's most bullish tech analysts, the real action is happening somewhere way less sexy: the data layer. Think of it like this: LLMs are becoming the commodity. They're getting cheaper, more accessible, and honestly, kind of boring. The actual money? That's in helping companies figure out what ...
Read More About This

Here's the thing about the AI gold rush: everyone's watching the wrong miners. Right now, the entire market is fixated on who's going to win the AI model wars. OpenAI versus Google versus Anthropic versus whoever's launching next week. It's like watching people argue about which website will dominate the internet while completely ignoring the fact that someone's making bank selling the routers that connect them all. That someone was Cisco during the dot-com era. They didn't have to pick the winning ...
Read More About This

As technology stocks consolidate their AI-driven gains, institutional money is flowing into one of the most historically reliable signals of a healthy economy: transportation stocks. Analysts at Ritholtz Wealth Management flagged that transports have moved onto their “Best Stocks in the Market” list as of June 15 — a momentum screen covering 193 names ranked by relative strength. The rotation makes fundamental sense: the US-Iran peace deal is set to reopen the Strait of Hormuz, lowering fuel costs and easing ...
Read More About This

Kevin Warsh takes his first Federal Reserve press conference podium this Wednesday carrying something his predecessor Jerome Powell rarely had: the genuine trust of the sitting president. But Warsh’s first meeting as Fed chair is unlikely to deliver the immediate rate cut Trump has publicly demanded. With core personal consumption expenditures inflation running at 3.3% — well above the Fed’s 2% target — Fed funds futures show virtually zero probability of a cut at the June meeting. What Warsh brings ...
Read More About This